7R5-32149-47126
3 vaccinations
3 coded responses
22 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 840 / UT
- Registered
- 2021-05-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-15
Registered in v-safe
-
2021-05-15
Dose 1 — Pfizer-BioNTech
-
2021-05-15
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-19
Survey response — days 1–6 daily, dose 1MedDRA: Insomnia — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: Having trouble sleepingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-20
- 2021-05-29
-
2021-06-05
Dose 2 — Pfizer-BioNTech
-
2021-06-05
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-06-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-06-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-06-19
- 2021-06-28
-
2021-07-12
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-17
- 2021-09-06
-
2021-12-06
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia — Feeling: FairFree text: Loss of smell and taste. Covid test pendingMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Dose 3 — Pfizer-BioNTech
-
2022-01-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2022-01-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2022-01-29
- 2022-02-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-15 | Pfizer-BioNTech | |
| 2 | 2021-06-05 | Pfizer-BioNTech | |
| 3 | 2022-01-15 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Having trouble sleeping
Release 9 — day 35, dose 2
Symptoms: Fatigue
Release 10 — 6 months, dose 2
Symptoms: Loss of smell and taste. Covid test pending
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release